Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG as adjuvant therapy for pediatric septic shock in PICU
PACTR202411838959146Recruiting
- Sponsor
- Pediatric Department, Alexandria University
- Start
- May 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of immune globulin in septic shock (2 arms), sponsored by Pediatric Department, Alexandria University. Primary endpoint: Death. Started May 2024; status: recruiting.
02
Drugs
immune globulin
03
Conditions
septic shock
Beyond the preview
Go deeper on PACTR202411838959146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202411838959146.